Chris Jenkins
Founder, CEO, Principal Partner
Marala McCallister
Chief Operations Officer
Drew Messick
Chief Financial Officer
Garry Coulson
Director, Regulatory
Patrick Conley
Director, IBC Operations
Shaun Tamprateep
IT & Operational Systems Architect
Sarah Attwood
Director, Client Services and Business Development
Jami Sentissi
Senior Associate Partner and IBC Training/Quality Improvement Specialist
Caitlyn Hauke
IBC Chair
Marilyn Lamm
IBC Chair
Nick Noriea
IBC Chair
Aswathy Sreedharan
Associate Partner & Gene Therapy Biosafety Officer
Cassandra Stark
Associate Partner & Gene Therapy Biosafety Officer
Chad Spruill
Associate Partner & Gene Therapy Biosafety Officer
Elena Mahrt
Associate Partner & Gene Therapy Biosafety Officer
Hallie Hoskins
Associate Partner & Gene Therapy Biosafety Officer
Katie George
Associate Partner & Gene Therapy Biosafety Officer
Jenni Smith
Associate Partner & Gene Therapy Biosafety Officer
Jessica Poole
Associate Partner & Gene Therapy Biosafety Officer
Marian Hemmelgarn
Associate Partner & Gene Therapy Biosafety Officer
Wendy Parrish
Associate Partner & Gene Therapy Biosafety Officer
Diane Brostrom
Associate Partner & Gene Therapy Biosafety Officer (Consultant)
Christine McFarland
Associate Partner & Gene Therapy Biosafety Officer (Consultant)
Sabena Blakeney
Associate Partner & Gene Therapy Biosafety Officer (Consultant)
Priya Kumar
Associate Partner & Gene Therapy Biosafety Officer (Consultant)
Sunny Hoffman
Client Services Partner
Paige Kobermann
Executive Assistant - Project Coordinator
Danielle Trbovich
Recruiting and Business Services Specialist
Shauna Pierce
Administrative Assistant
Amanda Wilson
Administrative Assistant
Amanda Bosco
Human Resources Manager
Brittany Dyer
Administrative Operations Manager
Connor Johnston
Marketing Specialist
Kaitlyn Le
Quality Manager
Larry Jones
Quality and Document Control Specialist
Rachel DePriest
Accounts Specialist
Venkatesh Movva
IT Support Specialist

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.